|
Oct 9
|
Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges
|
|
Oct 9
|
Even though Ardelyx (NASDAQ:ARDX) has lost US$210m market cap in last 7 days, shareholders are still up 352% over 3 years
|
|
Oct 9
|
Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
|
|
Oct 7
|
Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet
|
|
Sep 5
|
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
|
|
Aug 30
|
With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing
|
|
Jul 29
|
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
|
|
Jul 25
|
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jun 22
|
When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?
|
|
May 22
|
Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
|
|
May 16
|
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
|
|
May 7
|
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
|
|
May 4
|
Ardelyx, Inc. (NASDAQ:ARDX) Q1 2024 Earnings Call Transcript
|
|
May 4
|
Ardelyx First Quarter 2024 Earnings: Beats Expectations
|
|
May 3
|
Q1 2024 Ardelyx Inc Earnings Call
|
|
May 2
|
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 1
|
Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the National Kidney Foundation 2024 Spring Clinical Meetings
|
|
Apr 30
|
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
|
|
Apr 25
|
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|